NCT04997408

Brief Summary

Multidisciplinary rehabilitation facilitates functional recovery after stroke, and adherence to rehabilitation guidelines is associated with improved outcomes. We assessed the efficacy of a wearable device-assisted rehabilitation system in addition to conventional therapy compared to conventional therapy alone. A total of 127 eligible acute stroke inpatients were enrolled. There were 76 males (59.8%). The mean age of the participants was 57.45 years; 63 and 64 participants were randomized to the WG and CG, respectively. Both groups showed significant improvements in mRS scores at 90 days (WG: -0.68 \[95% confidence interval (CI), -0.94 to -0.42\]; CG: -0.56 \[95% CI, -0.74 to -0.38\]; P\<0.0001), but only the WG had significant improvements between 30 and 90 days (-0.36; 95% CI, -0.72, -0.007; P=0.049). Both groups had significant improvements in secondary outcomes at 90 days, but there was no difference between groups.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
Last Updated

May 17, 2022

Status Verified

May 1, 2022

Enrollment Period

2 years

First QC Date

July 31, 2021

Last Update Submit

May 15, 2022

Conditions

Keywords

RehabilitationStrokeMobile devicesTelemedicine

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale

    The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale, a global seven-level measure of functioning in which scores of 0 or 1 indicate a good outcome with no or minimal neurologic symptoms, scores of 2 to 5 indicate a poor outcome with increasing degree of disability, and 6 indicates death.

    Baseline, 30 days and 90 days

Secondary Outcomes (4)

  • Change in Barthel Index (BI) at 30 days, 90 days

    Baseline, 30 days and 90 days

  • Change in upper limb (UL) function (Stream Wolf Motor Function Test)

    Baseline, 30 days and 90 days

  • Change in functional status (Functional Independence Measure)

    Baseline, 30 days and 90 days

  • Change in static and dynamic balance ability (Berg balance scale)

    Baseline, 30 days and 90 days

Study Arms (2)

Study Arm

ACTIVE COMPARATOR

Mobile device-assisted rehabilitation

Device: Customized exercise appOther: In-person therapist-supervised rehabilitation

Control Arm

ACTIVE COMPARATOR

In-person therapist-supervised rehabilitation

Other: In-person therapist-supervised rehabilitation

Interventions

A Wearable Device-Based Assisted Post-Stroke Rehabilitation system

Study Arm

In-person therapist-supervised rehabilitation

Control ArmStudy Arm

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to provide signed informed consent prior to study entry and understand the nature of this study and agree to adhere to all study protocol requirements.
  • Males and females 20-75 years of age at the time of signing the informed consent
  • Patients with first-ever acute ischemic or hemorrhagic stroke diagnosed by a neurologist or neurosurgeon within 4-12 weeks of onset,
  • A baseline modified Rankin Scale score 2-4 on enrollment,
  • A designated caregiver for each patient willing to assist the patient to be engaged in WEAR using the mobile embedded with APP.

You may not qualify if:

  • Planning to have further rehabilitation in other hospital and could be followed up in the participating hospital.
  • The caregiver of patients not willing to assist patients to be engaged in WEAR.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ho HJ, Wu LC, Wu EH, Lee SF, Lee TH, Chiang SH, Chen CH, Chen HY, Pan SJ, Chen YW; WEAR-Stroke Study Group. Improving patient outcomes in acute and subacute stroke using a wearable device-assisted rehabilitation system: a randomized controlled trial. J Int Med Res. 2024 Oct;52(10):3000605241281425. doi: 10.1177/03000605241281425.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Prospective randomized study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2021

First Posted

August 9, 2021

Study Start

November 1, 2015

Primary Completion

November 1, 2017

Study Completion

April 1, 2018

Last Updated

May 17, 2022

Record last verified: 2022-05